NCT05819190View on ClinicalTrials.gov

Testing the Efficacy in Adults With Cold of HEalsea Rescue*

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Common Cold
Interventions
DEVICE

Healsea Rescue*

Subjects will be administered with Healsea Rescue\* by spraying 2 puffs in each nostril 2 times per day during 7 days.

DEVICE

Placebo

Subjects will be administered with isotonic saline nasal spray indistinguishable from the Healsea Rescue\* by spraying 2 puffs in each nostril 2 times per day during 7 days.

Trial Locations (1)

1000

DCC Convex Ltd., Sofia

Sponsors
All Listed Sponsors
lead

Lallemand Pharma AG

INDUSTRY

NCT05819190 - Testing the Efficacy in Adults With Cold of HEalsea Rescue* | Biotech Hunter | Biotech Hunter